ID   UN13B_RAT               Reviewed;        1622 AA.
AC   Q62769; Q9WV40;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 2.
DT   24-JUL-2024, entry version 164.
DE   RecName: Full=Protein unc-13 homolog B {ECO:0000305};
DE   AltName: Full=Munc13-2;
GN   Name=Unc13b {ECO:0000312|RGD:619723}; Synonyms=Unc13h2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7559667; DOI=10.1074/jbc.270.42.25273;
RA   Brose N., Hofmann K., Hata Y., Suedhof T.C.;
RT   "Mammalian homologues of Caenorhabditis elegans unc-13 gene define novel
RT   family of C2-domain proteins.";
RL   J. Biol. Chem. 270:25273-25280(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND INTERACTION
RP   WITH RIMS1.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11343654; DOI=10.1016/s0896-6273(01)00272-0;
RA   Betz A., Thakur P., Junge H.J., Ashery U., Rhee J.S., Scheuss V.,
RA   Rosenmund C., Rettig J., Brose N.;
RT   "Functional interaction of the active zone proteins Munc13-1 and RIM1 in
RT   synaptic vesicle priming.";
RL   Neuron 30:183-196(2001).
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9697857; DOI=10.1016/s0896-6273(00)80520-6;
RA   Betz A., Ashery U., Rickmann M., Augustin I., Neher E., Suedhof T.C.,
RA   Rettig J., Brose N.;
RT   "Munc13-1 is a presynaptic phorbol ester receptor that enhances
RT   neurotransmitter release.";
RL   Neuron 21:123-136(1998).
RN   [4]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=9895278; DOI=10.1042/bj3370363;
RA   Augustin I., Betz A., Herrmann C., Jo T., Brose N.;
RT   "Differential expression of two novel Munc13 proteins in rat brain.";
RL   Biochem. J. 337:363-371(1999).
CC   -!- FUNCTION: Plays a role in vesicle maturation during exocytosis as a
CC       target of the diacylglycerol second messenger pathway. Is involved in
CC       neurotransmitter release by acting in synaptic vesicle priming prior to
CC       vesicle fusion and participates in the activity-depending refilling of
CC       readily releasable vesicle pool (RRP) (By similarity). Essential for
CC       synaptic vesicle maturation in a subset of excitatory/glutamatergic but
CC       not inhibitory/GABA-mediated synapses (By similarity). In collaboration
CC       with UNC13A, facilitates neuronal dense core vesicles fusion as well as
CC       controls the location and efficiency of their synaptic release (By
CC       similarity). {ECO:0000250|UniProtKB:Q9Z1N9}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00041};
CC   -!- SUBUNIT: Interacts with RIMS1. {ECO:0000269|PubMed:11343654}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane protein.
CC       Cell membrane. Synapse. Note=Localized to synapses. Translocated to the
CC       plasma membrane in response to phorbol ester binding.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q62769-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q62769-2; Sequence=VSP_011384;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is ubiquitously expressed. Isoform 2 is
CC       expressed in brain, predominantly in cerebral cortex, hippocampus and
CC       striatum. {ECO:0000269|PubMed:11343654, ECO:0000269|PubMed:7559667,
CC       ECO:0000269|PubMed:9895278}.
CC   -!- DEVELOPMENTAL STAGE: First detected at birth, after which expression
CC       level is steadily increasing until it reaches a plateau at P15.
CC       {ECO:0000269|PubMed:9895278}.
CC   -!- DOMAIN: The C2 domains are not involved in calcium-dependent
CC       phospholipid binding.
CC   -!- SIMILARITY: Belongs to the unc-13 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U24071; AAC52267.1; -; mRNA.
DR   EMBL; AF159706; AAD41910.1; -; mRNA.
DR   PIR; I61776; I61776.
DR   RefSeq; NP_001036044.1; NM_001042579.1.
DR   RefSeq; NP_074053.1; NM_022862.1.
DR   AlphaFoldDB; Q62769; -.
DR   SMR; Q62769; -.
DR   CORUM; Q62769; -.
DR   STRING; 10116.ENSRNOP00000073250; -.
DR   PhosphoSitePlus; Q62769; -.
DR   PaxDb; 10116-ENSRNOP00000058802; -.
DR   GeneID; 64830; -.
DR   KEGG; rno:64830; -.
DR   UCSC; RGD:619723; rat. [Q62769-1]
DR   AGR; RGD:619723; -.
DR   CTD; 10497; -.
DR   RGD; 619723; Unc13b.
DR   eggNOG; KOG1011; Eukaryota.
DR   InParanoid; Q62769; -.
DR   OrthoDB; 5395569at2759; -.
DR   Reactome; R-RNO-181429; Serotonin Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-181430; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-264642; Acetylcholine Neurotransmitter Release Cycle.
DR   PRO; PR:Q62769; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0044305; C:calyx of Held; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0032009; C:early phagosome; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0048786; C:presynaptic active zone; ISO:RGD.
DR   GO; GO:0098831; C:presynaptic active zone cytoplasmic component; IBA:GO_Central.
DR   GO; GO:0042734; C:presynaptic membrane; IBA:GO_Central.
DR   GO; GO:0097470; C:ribbon synapse; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IBA:GO_Central.
DR   GO; GO:0043195; C:terminal bouton; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005516; F:calmodulin binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0019992; F:diacylglycerol binding; IEA:InterPro.
DR   GO; GO:0030742; F:GTP-dependent protein binding; ISO:RGD.
DR   GO; GO:0005543; F:phospholipid binding; IEA:InterPro.
DR   GO; GO:0019905; F:syntaxin binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0017075; F:syntaxin-1 binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0060478; P:acrosomal vesicle exocytosis; ISO:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0061789; P:dense core granule priming; IGI:SynGO-UCL.
DR   GO; GO:0060384; P:innervation; ISO:RGD.
DR   GO; GO:0031914; P:negative regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0007528; P:neuromuscular junction development; ISO:RGD.
DR   GO; GO:0099011; P:neuronal dense core vesicle exocytosis; ISS:UniProtKB.
DR   GO; GO:0090382; P:phagosome maturation; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1900426; P:positive regulation of defense response to bacterium; ISO:RGD.
DR   GO; GO:0045921; P:positive regulation of exocytosis; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0097151; P:positive regulation of inhibitory postsynaptic potential; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010808; P:positive regulation of synaptic vesicle priming; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0099525; P:presynaptic dense core vesicle exocytosis; ISO:RGD.
DR   GO; GO:0099161; P:regulation of presynaptic dense core granule exocytosis; IDA:SynGO.
DR   GO; GO:0048172; P:regulation of short-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0061669; P:spontaneous neurotransmitter secretion; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; ISO:RGD.
DR   GO; GO:0016081; P:synaptic vesicle docking; ISO:RGD.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; ISO:RGD.
DR   GO; GO:0016082; P:synaptic vesicle priming; IMP:ParkinsonsUK-UCL.
DR   CDD; cd20859; C1_Munc13-2-like; 1.
DR   CDD; cd08394; C2A_Munc13; 1.
DR   CDD; cd04027; C2B_Munc13; 1.
DR   CDD; cd08395; C2C_Munc13; 1.
DR   Gene3D; 1.10.357.50; -; 1.
DR   Gene3D; 1.20.58.1100; -; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 3.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR010439; MUN_dom.
DR   InterPro; IPR014770; Munc13_1.
DR   InterPro; IPR014772; Munc13_dom-2.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR027080; Unc-13.
DR   InterPro; IPR037302; Unc-13_C2B.
DR   PANTHER; PTHR10480; PROTEIN UNC-13 HOMOLOG; 1.
DR   PANTHER; PTHR10480:SF8; PROTEIN UNC-13 HOMOLOG B; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00168; C2; 3.
DR   Pfam; PF06292; MUN; 1.
DR   PRINTS; PR00360; C2DOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00239; C2; 3.
DR   SMART; SM01145; DUF1041; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 3.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   PROSITE; PS50004; C2; 3.
DR   PROSITE; PS51258; MHD1; 1.
DR   PROSITE; PS51259; MHD2; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Coiled coil; Cytoplasm;
KW   Exocytosis; Membrane; Metal-binding; Phosphoprotein; Reference proteome;
KW   Repeat; Synapse; Zinc; Zinc-finger.
FT   CHAIN           1..1622
FT                   /note="Protein unc-13 homolog B"
FT                   /id="PRO_0000188577"
FT   DOMAIN          1..97
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          596..720
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1025..1168
FT                   /note="MHD1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00587"
FT   DOMAIN          1275..1417
FT                   /note="MHD2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00588"
FT   DOMAIN          1450..1577
FT                   /note="C2 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   ZN_FING         490..540
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          189..280
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          292..357
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1210..1231
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        190..205
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        206..226
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        237..254
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        264..280
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        292..307
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        330..351
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         629
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         629
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         635
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         681
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         681
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         683
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         683
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         700
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14795"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14795"
FT   MOD_RES         378
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14795"
FT   VAR_SEQ         1..400
FT                   /note="MSLLCVRVKRAKFQGSPDKFNTYVTLKVQNVKSTTVAVRGDQPSWEQDFMFE
FT                   ISRLDLGLSVEVWNKGLIWDTMVGTVWIALKTIRQSDEEGPGEWSTLEAETLMKNDEIC
FT                   GTKNPTPHKILLGTRFELPFDIPEEEARYWTYKLEQINALADDNEYSSQEESQRKLLPT
FT                   AAAQCRHWTYLGWGEHQTFEDPDSAVDDRDSDYRSETSNSAPPPYHTTTQPNASAHQFP
FT                   MPVPLPQQLFLQGSSRDSCNDSMQSYDLDYPERRALSPTSSSRYGSSCNVSRGSSLLSE
FT                   LDQYHEQDDDGRERDSIHSSHSYGSLSRDGQAGLGEQEKALEVACESQKEKTGESKERD
FT                   DATVCPPSDLMLHKDLTLGPQESFPEEKASSPFTQARAHWFRAVTKVRLQLQE -> MK
FT                   RLLRESEEEIMLTLGPSSSLSPDQVRTETVCIVKGKSTGPTGSLPEDNFPPPCCESADS
FT                   TTSGERDRNLAQLGSFEQQASSQPSLACTACASGSDSRELSPASITSCSEPSERNKARP
FT                   IFPRGPGQRCRHEHQEPLGDVVEYIIRELQGISRLQSEIAELQQHLNQVRGSVDEVSSC
FT                   VDSVLSEIEGLHVGSSSLGKVRHGEKAQELHVERSREEAILYLYGLPEHDGESTVELVD
FT                   NFLAKHLCVNGMQCNRYVREAYRAGTAPAPRPTVVKLVHPEHRDLILQKSILLQSVGVR
FT                   VATREEPVWPEGCKNPPKESLSCLQQFQDHSRNHQGKPALQLETGNRRQMSGPHQMRTQ
FT                   NQHRELQASEHQGLSFLPKDGSAKQSDVSKLQDEVKGTSGAPQVISDPCGELSLLHQLE
FT                   GSSPVLIPKEEDCGKLQIFKQDSQEHKACNVTKLQSDCNNAIKASSCLSLSGPLKAEKV
FT                   NAEDRMLGGEDGLDILSPKQLEDLLADKSRRFATLNPDSAVEEVIIGPETFSNMVHIDL
FT                   NEEETCTAQVLKNVFDKSSCVLGGSQEDEDVEIKFHTTKLSRAIHHFRLALQGVFQKLE
FT                   NNGSISPEDLESNESGSQSENSDRLLWTVSSGGAHDCSVESPASQGSESLLSVVSGGVG
FT                   ISVQGDQTPQAPSNFSLASNNSPLTNSLLSFPLAPGLGNETCSRPDSPNQGKLSLEQVC
FT                   AETIYLNKCINNFKNVLREKRLRQKKLLQELVQTASHLSVEDIPSEGKREALQ (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7559667"
FT                   /id="VSP_011384"
SQ   SEQUENCE   1622 AA;  184063 MW;  885C210A13086ACD CRC64;
     MSLLCVRVKR AKFQGSPDKF NTYVTLKVQN VKSTTVAVRG DQPSWEQDFM FEISRLDLGL
     SVEVWNKGLI WDTMVGTVWI ALKTIRQSDE EGPGEWSTLE AETLMKNDEI CGTKNPTPHK
     ILLGTRFELP FDIPEEEARY WTYKLEQINA LADDNEYSSQ EESQRKLLPT AAAQCRHWTY
     LGWGEHQTFE DPDSAVDDRD SDYRSETSNS APPPYHTTTQ PNASAHQFPM PVPLPQQLFL
     QGSSRDSCND SMQSYDLDYP ERRALSPTSS SRYGSSCNVS RGSSLLSELD QYHEQDDDGR
     ERDSIHSSHS YGSLSRDGQA GLGEQEKALE VACESQKEKT GESKERDDAT VCPPSDLMLH
     KDLTLGPQES FPEEKASSPF TQARAHWFRA VTKVRLQLQE ISDDGDPSLP QWLPEGPAGG
     LYGIDSMPDL RRKKPLPLVS DLAMSLVQSR KAGITSAMAT RTSLKDEDLK SHVYKKTLQA
     LIYPISCTTP HNFEVWSATT PTYCYECEGL LWGLARQGMR CSECGVKCHE KCQDLLNADC
     LQRAAEKSSK HGAEDRTQNI IMAMKDRMKI RERNKPEIFE VIRDVFTVSK VAHVQQMKTV
     KQSVLDGTSK WSAKITITVV CAQGLQAKDK TGSSDPYVTV QVGKTKKRTK TIFGNLNPVW
     EEKFHFECHN SSDRIKVRVW DEDDDIKSRV KQRLKRESDD FLGQTIIEVR TLSGEMDVWY
     NLEKRTDKSA VSGAIRLQIN VEIKGEEKVA PYHVQYTCLH ENLFHYLTDI QGSGGVWIPD
     ARGDDAWKVY FDETAQEIVD EFAMRYGIES IYQAMTHFAC LSSKYMCPGV PAVMSTLLAN
     INAYYAHTTA STNVSASDRF AASNFGKERF VKLLDQLHNS LRIDLSTYRN NFPAGSPERL
     QDLKSTVDLL TSITFFRMKV QELQSPPRAS QVVKDCVKAC LNSTYEYIFN NCHDLYSHQY
     QLQEQPLEEP GPSIRNLDFW PKLITLIVSI IEEDKNSYTP VLNQFPQELN VGKVSAEVMW
     HLFAQDMKYA LEEHEKDRLC KSADYMNLHF KVKWLHNEYV RELPALQGQV PEYPAWFEQF
     VLQWLDENED VSLEFLRGGL ERDKRDGFQQ TSEHALFSCS VVDVFTQLNQ SFEIIRKLEC
     PDPSILAHYM RRFAKTIGKV LIQYADILSK NFPAYCTKER LPCILMNNMQ QLRVQLEKMF
     EAMGGKELDS EAADSLKELQ VKLNTVLDEL SMVFGNSFQV RIDECVRQMA DILGQVRGTG
     NASPNARASV AQDADSVLRP LMDFLDGNLT LFATVCEKTV LKRVLKELWR VVMNTMERVI
     VLPPLIDQTG TQLILTAAKE LSQLSKLKDH MVREETRNLT PKQCAVLDLA LDTVKQYFHA
     GGNGLKKTFL EKSPDLQSLR YALSLYTQTT DTLIKTFVRS QTAQVHDGKG IRFTANEDIR
     PEKGAGVDDP VGEVSIQVDL FTHPGTGEHK VTVKVVAAND LKWQTAGMFR PFVEVTMVGP
     HQSDKKRKFT TKSKSNSWTP KYNETFHFLL GNEEGPEAYE LQICVKDYCF AREDRVIGLA
     VMPLRDVAAK GSCACWCPLG RKIHMDETGM TILRILSQRS NDEVAREFVK LKSESRSIEE
     GS
//
